porno atasehir escort bostanci escort erenkoy escort goztepe escort kadikoy Escort kartal Escort maltepe Escort suadiye Escort uskudar Escort umraniye Escort kartal escort bostanci escort atasehir escort kadikoy escort kurtkoy escort tuzla escort erenkoy escort beykoz escort umraniye escort pendik escort kadikoy escort maltepe escort antalya escort konya escort

Market Research Reports and Industry Reports

Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vectura Group Plc (Vectura) is a formulation and device business for inhaled airways products providing an integrated inhaled drug delivery platform. It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases. The company develops products based on a wide range of proprietary lung delivery technologies, including device and formulation capabilities. Vectura has a varied portfolio of drugs in clinical development, comprising several novel and generic programs that are partnered with several global biotechnology and pharmaceutical companies. Vectura is headquartered in Chippenham, Wiltshire, the UK.

Vectura Group Plc Key Recent Developments

Sep 06,2017: Vectura Group: 2017 Interim Results
Mar 21,2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016
Mar 21,2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016
Mar 06,2017: Vectura Group: Board Change
Feb 16,2017: Vectura achieves 9 million royalty cap from GSK Ellipta products

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Vectura Group Plc - Key Facts 5
Vectura Group Plc - Key Employees 6
Vectura Group Plc - Key Employee Biographies 7
Vectura Group Plc - Major Products and Services 8
Vectura Group Plc - History 10
Vectura Group Plc - Company Statement 13
Vectura Group Plc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 Company Analysis 16
Vectura Group Plc - Business Description 16
Vectura Group Plc - Corporate Strategy 17
Vectura Group Plc - SWOT Analysis 18
SWOT Analysis - Overview 18
Vectura Group Plc - Strengths 18
Vectura Group Plc - Weaknesses 19
Vectura Group Plc - Opportunities 20
Vectura Group Plc - Threats 21
Vectura Group Plc - Key Competitors 22
Section 3 Company Financial Ratios 23
Financial Ratios - Capital Market Ratios 23
Financial Ratios - Annual Ratios 24
Performance Chart 27
Financial Performance 27
Financial Ratios - Interim Ratios 28
Financial Ratios - Ratio Charts 29
Section 4 Companys Lifesciences Financial Deals and Alliances 30
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31
Vectura Group Plc, Recent Deals Summary 32
Section 5 Companys Recent Developments 33
Sep 06, 2017: Vectura Group: 2017 Interim Results 33
Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016 35
Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016 37
Mar 06, 2017: Vectura Group: Board Change 38
Feb 16, 2017: Vectura achieves 9 million royalty cap from GSK Ellipta products 39
Jan 25, 2017: Seebri / Ultibro Breezhaler 2016 sales reach $512 million triggering $5 million milestone receipt 40
Jan 11, 2017: Vectura Group: Pre-close update 41
Aug 05, 2016: Vectura Group: US$8 million Exparel sales milestone from Pacira triggered 42
Jul 27, 2016: Vectura initiates legal proceedings against GSK relating to option-to-licence patent agreement and confirms 2016 revenue guidance 43
Jul 08, 2016: Dr John Brown, Non-Executive Director, confirms date to step down 44
Section 6 Appendix 45
Methodology 45
Ratio Definitions 45
About GlobalData 49
Contact Us 49
Disclaimer 49

List Of Tables

List of Tables
Vectura Group Plc, Key Facts 5
Vectura Group Plc, Key Employees 6
Vectura Group Plc, Key Employee Biographies 7
Vectura Group Plc, Major Products and Services 8
Vectura Group Plc, History 10
Vectura Group Plc, Subsidiaries 15
Vectura Group Plc, Key Competitors 22
Vectura Group Plc, Ratios based on current share price 23
Vectura Group Plc, Annual Ratios 24
Vectura Group Plc, Annual Ratios (Cont...1) 25
Vectura Group Plc, Annual Ratios (Cont...2) 26
Vectura Group Plc, Interim Ratios 28
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 30
Vectura Group Plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 31
Vectura Group Plc, Recent Deals Summary 32
Currency Codes 45
Capital Market Ratios 45
Equity Ratios 46
Profitability Ratios 46
Cost Ratios 47
Liquidity Ratios 47
Leverage Ratios 48
Efficiency Ratios 48

Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review

Vectura Group Plc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Vectura Group Plc (VEC) - Medical Equipment - Deals and Alliances Profile.

Vectura Group Plc (Vectura) is a pharmaceutical product development company that develops inhaled pharmaceutical therapies for treating various respiratory diseases. The company offers its products for the treatment of airways

USD 250View Report

FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review

FirstGroup plc (FGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData

USD 125View Report

Intercontinental Hotels Group Plc in Travel (World)

IHGs 2017 results showed an uplift of RevPAR, and a 4% increase in fee revenues. The 7% growth of operating profits shows that the asset-light model is working for

USD 572View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)


+91 9987 2952 42

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Oct 2017
No. of Pages :49
Country :United Kingdom
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube